
Canary ETF Filing Sends INJ Higher: Can Injective Price Reach $7 Next?
Injective price surged nearly 10% following renewed optimism surrounding Canary Capital’s proposed staked INJ ETF boosted investor sentiment. The latest filing provides greater regulatory cla
